DNAPrint Genomics, Inc. (DNAG)

Market Cap	1.30K -99.9%
Revenue (ttm)	1.93M -15.2%
Net Income	-4.55M
EPS	-0.01
Shares Out	1.29B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	331,500
Average Volume	102,398
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	0.0000 - 0.0001
Beta	86.80
RSI	48.15
Earnings Date	n/a

About DNAPrint Genomics

DNAPrint Genomics, Inc. engages in the development and marketing of genetic testing products and services. It offers AncestryByDNA, a pan-chromosomal assay for genetic ancestry; EurasianDNA, which measures European sub-ancestry; EuropeanDNA, which reports a customer's proportional basic continental European ancestry; DNAWitness to determine genetic heritage from DNA samples obtained from crime scenes; RETINOME, which provides a physical portrait of a person of interest for a detective based on a DNA sample from a crime scene or remains of an in...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1983
• Employees: 25
• Stock Exchange: OTCMKTS
• Ticker Symbol: DNAG

Financial Performance

In 2006, DNAPrint Genomics's revenue was $2.43 million, an increase of 90.75% compared to the previous year's $1.28 million. Losses were -$12.35 million, 41.7% more than in 2005.